雲計算板塊走強 美利雲、科創信息漲停
格隆匯3月24日丨雲計算板塊走強,美利雲、科創信息漲停,奧飛數據、科華恆盛漲超8%,順網科技、證通電子等跟漲。調研機構Canalys近日發佈了2019年第四季度中國公有云服務市場報告。報告顯示,2019年第四季度,中國雲計算市場規模達33億美元,增長率為66.9%,持續保持高速增長。Canalys認為,在應對新冠肺炎疫情方面,中國雲服務商反映迅速,為政府、企業提供了雲端計算能力、數字化系統、人工智能等服務,做出了突出貢獻。在此帶動下,2020年雲計算市場前景可觀,政府和企業上雲意願加強,大部分企業正在評估上雲路徑,將會在未來三四個月內採取實際行動,這讓雲計算服務商將獲得更多的新客户。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.